A jury in the city of Philadelphia awarded a plaintiff suffering from cancer, on Friday, $2.25 billion, according to what the man’s lawyer confirmed to AFP. The plaintiff, John McIveson, blamed Roundup for his cancer, called non-Hodgkin's lymphoma.
Bayer told AFP she would appeal the ruling. The company denies that glyphosate is a carcinogen. This question has been controversial in science for years. In November, the European Union Commission extended approval of the weedkiller for ten years.
Involved in legal proceedings since the acquisition
Bayer acquired Roundup maker Monsanto for $63 billion in 2018, and has been mired in legal action ever since. The company was ordered to pay damages in a number of glyphosate-related rulings, but was acquitted in others. Settlements have been concluded in many cases.
According to Bayer, about 113,000 cases have been completed out of 160,000 filed by alleged victims so far. The group has allocated allocations for this amount amounting to $16 billion.
“Tv expert. Hardcore creator. Extreme music fan. Lifelong twitter geek. Certified travel enthusiast. Baconaholic. Pop culture nerd. Reader. Freelance student.”
More Stories
Deal of the Day – Cordless Hand and Stick Vacuum Cleaner
It is better not to enter the house anymore – inside Paradeplatz
BMW has delivered vehicles containing banned Chinese parts to the United States